. Validation of Assays for Measurement of Amyloid-β Peptides in Cerebrospinal Fluid and Plasma Specimens from Patients with Alzheimer's Disease Treated with Solanezumab. J Alzheimers Dis. 2013 Jan 1;34(4):897-910. PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.